Q
Qi-Yan Zhu
Researcher at Centers for Disease Control and Prevention
Publications - 8
Citations - 128
Qi-Yan Zhu is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 106 citations.
Papers
More filters
Journal ArticleDOI
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial
Fengcai Zhu,Zhenglun Liang,Xiu-Ling Li,Heng-Ming Ge,Fan-Yue Meng,Qunying Mao,Yun-Tao Zhang,Yuemei Hu,Zhen-Yu Zhang,Jingxin Li,Fan Gao,Qing-Hua Chen,Qi-Yan Zhu,Kai Chu,Xing Wu,Xin Yao,Hui-Jie Guo,Xiao-Qin Chen,Pei Liu,Yu-Ying Dong,Feng-Xiang Li,Xin-Liang Shen,Junzhi Wang +22 more
TL;DR: Taking immunogenicity, safety, and production capacity into account, the 320 U alum-adjuvant formulation of the EV71 vaccine is probably the best possible formulation for phase 3 trials.
Journal ArticleDOI
Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infants.
Fengcai Zhu,Junzhi Wang,Xiu-Ling Li,Zhenglun Liang,Heng-Ming Ge,Fan-Yue Meng,Qunying Mao,Yun-Tao Zhang,Zhen-Yu Zhang,Hong Ji,Fan Gao,Hui-Jie Guo,Qi-Yan Zhu,Kai Chu,Xing Wu,Jingxin Li,Qing-Hua Chen,Xiao-Qin Chen,Wei-wei Zhang,Hu Yuemei,Liang Li,Feng-Xiang Li,Xin Yao,Pei Liu,Hua Wang,Xin-Liang Shen +25 more
TL;DR: This study found that the inactivated EV71 vaccine was well tolerated and had good immunogenicity in healthy children and infants.
Journal ArticleDOI
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Jitao Wang,Qiran Zhang,Jing-Wen Ai,Dengxiang Liu,Chuan Liu,Huiling Xiang,Ye Gu,Ying Guo,Jiaojian Lv,Yifei Huang,Yanna Liu,Danqing Xu,Shubo Chen,Jinlong Li,Qianqian Li,Jing Liang,Lidan Bian,Zhen Zhang,Xiao-Qing Guo,Yinong Feng,Luxiang Liu,Xuying Zhang,Yanliang Zhang,Faren Xie,Shujun Jiang,Wei Qin,Xiaodong Wang,Wei Rao,Qun Zhang,Qiuju Tian,Ying-he Zhu,Qingwei Cong,Juan Xu,Zhiyun Hou,Nina Zhang,Aiguo Zhang,Hongmei Zu,Yun Wang,Zhao Yan,Xiufang Du,A. Hou,Yan Yan,Yuanwang Qiu,Hang-Yuan Wu,Sheng-Juan Hu,Yanhong Deng,Jiansong Ji,Jie Yang,Jiansheng Huang,Zhongwei Zhao,Shengqiang Zou,Hailei Ji,Guohong Ge,L X Zhong,Song He,Xia Yan,Bianba Yangzhen,Ci Qu,Liting Zhang,Shi Joon Yang,Xiaoqin Gao,Muhan Lv,Qi-Yan Zhu,Xinxin Xu,Qing-Lei Zeng,Xian Qi,Wenhong Zhang +66 more
TL;DR: Wang et al. as mentioned in this paper reported that COVID-19 vaccines are safe with acceptable immunogenicity in cirrhotic patients, and Child-Pugh score of B and C levels was an independent risk factor of negative neutralizing antibody.
Journal ArticleDOI
Hepatic artery pseudoaneurysm caused by chronic pancreatitis: Case report and literature review
TL;DR: In this paper , a 42-year-old man with chronic pancreatitis developed right hepatic artery pseudoaneurysm (HAP), and finally he was treated with intravascular embolization.
Posted ContentDOI
Comparing Impacts of Different Bowel Cleansing Agents and Oral Probiotics After Cleansing On Symptom and Microbiota: a Randomized Placebo-Controlled Trial
Penghui Dai,Feng Tang,Ke Gan,Qing Hu,Jingyu Liao,Xiaoyu Li,Lei Shi,Wei Zhang,Hailin Zhang,Qi-Yan Zhu,Yong Cheng,J. Zheng,Jie Chen,Ming Han,Muhan Lv,Mingming Deng,Hongfen Xia,Gang Luo +17 more
TL;DR: Mirabilite could be an optimal bowel cleansing agent for healthy people and can be applied broadly and probiotics are suggested to administrate after bowel cleansing as it brings multiple benefits in this study.